A new control switch could make RNA therapies easier to program
Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.
3 Questions: Mriganka Sur on the research origins of the first approved drug to treat Rett syndrome
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.
New purification method could make protein drugs cheaper
MIT engineers find specialized nanoparticles can quickly and inexpensively isolate proteins from a bioreactor.
MIT-Takeda Program heads into fourth year with crop of 10 new projects
The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.
A new educational program for scientists working on substance use disorder
MIT Open Learning team awarded NIH grant to provide training in biomedical product development, entrepreneurship, and innovation.
Startups led by MIT mechanical engineers offer health care solutions
Companies founded by MechE faculty and alumni solve a variety of health care challenges, from better drug delivery to robotic surgery.
2022-23 Takeda Fellows: Leveraging AI to positively impact human health
New fellows are working on health records, robot control, pandemic preparedness, brain injuries, and more.
Professor Emeritus Richard Wurtman, influential figure in translational research, dies at 86
Longtime MIT professor of neuroscience led research behind 200 patents, laying the groundwork for numerous medical products.
Angela Koehler takes on the most challenging drug targets
Using biological, chemical, and engineering tools, she has developed strategies to attack molecules once thought to be “undruggable.”
The economics of missed opportunities
Danielle Li takes a close look at scientific practices and organizational decisions — and provides data about improving them.
Artificial intelligence model can detect Parkinson’s from breathing patterns
An MIT-developed device with the appearance of a Wi-Fi router uses a neural network to discern the presence and severity of one of the fastest-growing neurological diseases in the world.
Artificial intelligence model finds potential drug molecules a thousand times faster
A geometric deep-learning model is faster and more accurate than state-of-the-art computational models, reducing the chances and costs of drug trial failures.
Can artificial intelligence overcome the challenges of the health care system?
MIT and Mass General Brigham researchers and physicians connect in person to bring AI into mainstream health care.
3 Questions: Daniel Anderson on the progress of mRNA vaccines
Following the successful development of vaccines against Covid-19, scientists hope to deploy mRNA-based therapies to combat many other diseases.
Q&A: Chris Rackauckas on the equations at the heart of practically everything
Have a question about numerical differential equations? Odds are this CSAIL research affiliate has already addressed it.